CCDC86 and central nervous system cancer: More importantly, Kaplan–Meier survival analysis unveiled a substantial association of CCDC86 expression with overall survival and disease-free survival in glioma patients (Fig. 1B), highlighting its potential as a prognostic marker for this disease.